IntelliCell to Sell EMD Millipore's Guava Platform for SVF Applications | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – IntelliCell BioSciences today announced an exclusive agreement to sell and distribute EMD Millipore's Guava flow cytometry platform for stromal vascular fraction (SVF) applications.

IntelliCell manufactures SVF containing stem cells derived from fatty tissue. The deal streamlines the development of IntelliCell's tissue processing centers in the US, the New York-based company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.